Chemical | 22 July 2021
Rallis India reports Q1FY22 consolidated PAT at Rs. 82.34 Cr
The company posted net profit of Rs.91.87 crores for the period ended June 30, 2020.
The company posted net profit of Rs.91.87 crores for the period ended June 30, 2020.
The company reported total income of Rs.174.08 crores during the period ended June 30, 2021.
The company has posted net profit of Rs.9.92 crores for the period ended June 30, 2020.
The company generated strong growth rates and continued its growth trajectory, with a new sales record of CHF 4,448.7 million
The company posted net loss of Rs. (20.10) crores for the period ended June 30, 2020.
The company has further reduced the net debt by Rs 45 crore in Q1'FY22.
The company has reported total income of Rs.2025.11 crores during the period ended June 30, 2021.
Crude oil prices have been rising and, along with that, key input prices are up too. Hence, HDFC Securities expects blended gross and EBITDA margins to decline.
The order has been received from one of the world's most prominent soda ash manufacturing companies based in Russia
The Board had approved a project for setting up of BOPP Film Line in Thailand by SRF Industries (Thailand) Ltd., a wholly owned subsidiary of the company
The distillation capacity of Ajbapur Plant is increased from 200 KLPD (Kilo Litre Per Day) to additional 120 KLPD taking the total to 320 KLPD
The acquisitions will also expand Rossari’s footprint in exports market, which has been limited so far.
The acquisition strengthens Sika’s roofing and waterproofing portfolio, and complements Sika’s sustainability focus
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
The company has managed to show leadership by creating dedicated investment to appropriately balance environmental targets and long-term sustainable business growth coupled with digital adoption to enhance operations
Earlier, the USFDA has granted ‘Orphan Drug Designation’ and ‘Fast Track Designation’ to Saroglitazar Mg for PBC
The US FDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th of July 2021
The plant will become operational by late 2023 and this investment is planned as the first of three phase investment
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
Oil price rise made profit from their inventory, letting them to make profits continuously in oil refinery industry
TotalEnergies - Gurin Energy selects Saft’s battery energy storage system for first Japanese project
Subscribe To Our Newsletter & Stay Updated
